You are here: Home » News-CM » Companies » Results
Business Standard

Sterling Biotech reports standalone net loss of Rs 109.50 crore in the June 2017 quarter

Capital Market 

Sales decline 0.06% to Rs 94.82 crore

Net Loss of reported to Rs 109.50 crore in the quarter ended June 2017 as against net loss of Rs 87.54 crore during the previous quarter ended June 2016. Sales declined 0.06% to Rs 94.82 crore in the quarter ended June 2017 as against Rs 94.88 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales94.8294.88 0 OPM %0.5311.60 -PBDT-100.77-67.63 -49 PBT-167.45-133.87 -25 NP-109.50-87.54 -25

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, August 12 2017. 17:35 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU